Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinibAndreas Hochhaus, H. Kantarjian, Francisco Cervantes et al.|Leukemia|2008Cited by 354
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-ISrđan Verstovšek, H. Kantarjian, Ruben A. Mesa et al.|Haematologica|2013Cited by 162
Fever, infection and host resistance in acute leukemiaRichard T. Silver, Norman B. McCullough, John P. Utz et al.|The American Journal of Medicine|1958Cited by 92
Personalized Transplant Decision Making for Myelofibrosis in the Era of Molecular Genetics and JAK InhibitionNico Gagelmann, Nicolaus Kröger, Bárbara Mora et al.|Blood|2024Cited by 3